GESTABLISS Injection:
Indication: Specifically formulated for the management of uterine prolapse in animals.
Composition: Contains Hydroxyprogesterone Caproate at a concentration of 0.25gm/ml.
Dosage and Administration: Administered via the intramuscular (I.M.) route. Recommended dosage: 3ml. Typically administered on the 3rd and 5th day following the diagnosis of uterine prolapse.
Advantages:
- Offers an effective solution for uterine prolapse management in animals.
- Provides a long-acting therapeutic effect for sustained relief.
- Convenient packaging ensures ease of administration and handling.